IL6 and recessive dystrophic epidermolysis bullosa: The hyper-activation of the IL-6 signaling cascade could at least partly explain the increased risk of RDEB patients to develop aggressive SCCs, and, in turn, represents a novel prognostic and therapeutic target in RDEB-SCC [72,77].